|
1
|
Weintraub S, Karpouzian-Rogers T, Peipert
JD, Nowinski C, Slotkin J, Wortman K, Ho E, Rogalski E, Carlsson C,
Giordani B, et al: ARMADA: Assessing reliable measurement in
Alzheimer's disease and cognitive aging project methods. Alzheimers
Dement. 18:1449–1460. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
GBD 2019 Dementia Forecasting
Collaborators, . Estimation of the global prevalence of dementia in
2019 and forecasted prevalence in 2050: An analysis for the global
burden of disease study 2019. Lancet Public Health. 7:e105–e125.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zetterberg H and Mattsson N: Understanding
the cause of sporadic Alzheimer's disease. Expert Rev Neurother.
14:621–630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leng F and Edison P: Neuroinflammation and
microglial activation in Alzheimer disease: Where do we go from
here? Nat Rev Neurol. 17:157–172. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Del Bo R, Angeretti N, Lucca E, De Simoni
MG and Forloni G: Reciprocal control of inflammatory cytokines,
IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci
Lett. 188:70–74. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Akiyama H, Barger S, Barnum S, Bradt B,
Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich
BL, et al: Inflammation and Alzheimer's disease. Neurobiol Aging.
21:383–421. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Busche MA and Hyman BT: Synergy between
amyloid-β and tau in Alzheimer's disease. Nat Neurosci.
23:1183–1193. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haass C and Selkoe D: If amyloid drives
Alzheimer disease, why have anti-amyloid therapies not yet slowed
cognitive decline? PLoS Biol. 20:e30016942022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thakur S, Dhapola R, Sarma P, Medhi B and
Reddy DH: Neuroinflammation in Alzheimer's disease: Current
progress in molecular signaling and therapeutics. Inflammation.
46:1–17. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hofmann LP, Ren S, Schwalm S,
Pfeilschifter J and Huwiler A: Sphingosine kinase 1 and 2 regulate
the capacity of mesangial cells to resist apoptotic stimuli in an
opposing manner. Biol Chem. 389:1399–1407. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kunkel GT, Maceyka M, Milstien S and
Spiegel S: Targeting the sphingosine-1-phosphate axis in cancer,
inflammation and beyond. Nat Rev Drug Discov. 12:688–702. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spiegel S and Milstien S:
Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat Rev Mol
Cell Biol. 4:397–407. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alvarez SE, Harikumar KB, Hait NC,
Allegood J, Strub GM, Kim EY, Maceyka M, Jiang H, Luo C, Kordula T,
et al: Sphingosine-1-phosphate is a missing cofactor for the E3
ubiquitin ligase TRAF2. Nature. 465:1084–1088. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang C, Xu T, Lachance BB, Zhong X, Shen
G, Xu T, Tang C and Jia X: Critical roles of sphingosine kinase 1
in the regulation of neuroinflammation and neuronal injury after
spinal cord injury. J Neuroinflammation. 18:502021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee JY, Han SH, Park MH, Song IS, Choi MK,
Yu E, Park CM, Kim HJ, Kim SH, Schuchman EH, et al: N-AS-triggered
SPMs are direct regulators of microglia in a model of Alzheimer's
disease. Nat Commun. 11:23582020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu H, Lu X, Hu Y and Fan X: Chemical
constituents of Panax ginseng and Panax notoginseng explain
why they differ in therapeutic efficacy. Pharmacol Res.
161:1052632020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang D, Liu J, Bilinski K, Xu L, Steiner
GZ, Seto SW and Bensoussan A: Herbal medicine for the treatment of
vascular dementia: An overview of scientific evidence. Evid Based
Complement Alternat Med. 2016:72936262016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng L, Han F, Zhou L, Wu S, Du Y, Zhang
D, Zhang C and Gao Y: Efficacy and safety of Panax notoginseng
saponins (Xueshuantong) in patients with acute ischemic stroke
(EXPECT) trial: Rationale and design. Front Pharmacol.
12:6489212021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen M, Zhou SQ, Liu L, Wen YX and Chen
LB: Notoginsenoside R1 alleviates the inflammation of
osteoarthritis by activating the Nrf2/HO-1 signalling pathway in
vitro and in vivo. J Funct Foods. 85:1046662021. View Article : Google Scholar
|
|
20
|
Wang M, Liu H, Xu L, Li M and Zhao M: The
protective effect of notoginsenoside R1 on isoflurane-induced
neurological impairment in the rats via regulating miR-29a
expression and neuroinflammation. Neuroimmunomodulation. 29:70–76.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu T, Li S, Liang WQ, Li SS, Lu MN, Chen
B, Zhang L, Mao R, Ding WH, Gao WW, et al: Notoginsenoside
R1-induced neuronal repair in models of Alzheimer disease is
associated with an alteration in neuronal hyperexcitability, which
is regulated by Nav. Front Cell Neurosci. 14:2802020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Li B, Yu X, Zhou Y and Gao Y: The
neuroprotective effect of GM-1 ganglioside on the
amyloid-beta-induced oxidative stress in PC-12 cells mediated by
Nrf-2/ARE signaling pathway. Neurochem Res. 47:2405–2415. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cieślik M, Czapski GA and Strosznajder JB:
The molecular mechanism of amyloid β42 peptide toxicity: The role
of sphingosine kinase-1 and mitochondrial sirtuins. PLoS One.
10:e01371932015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gassowska M, Cieslik M, Wilkaniec A and
Strosznajder JB: Sphingosine kinases/sphingosine-1-phosphate and
death signalling in APP-transfected cells. Neurochem Res.
39:645–652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Wei L, Zhu J, He B, Kong B, Jin Y
and Fu Z: Tetrabromoethylcyclohexane (TBECH) exhibits
immunotoxicity in murine macrophages. Environ Toxicol. 35:159–166.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ni L, Zhuge F, Yang S, Ma L, Zheng A, Zhao
Y, Hu L, Fu Z and Ni Y: Hydrolyzed chicken meat extract attenuates
neuroinflammation and cognitive impairment in middle-aged mouse by
regulating M1/M2 microglial polarization. J Agric Food Chem.
69:9800–9812. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ni Y, Ni L, Ma L, Wang Z, Zhao Y, Hu L,
Zheng L and Fu Z: Neuroprotective effects of ProBeptigen/CMI-168 on
aging-induced cognitive decline and neuroinflammation in mice: A
comparison with essence of chicken. Acta Biochim Biophys Sin
(Shanghai). 53:419–429. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma L, Ni Y, Wang Z, Tu W, Ni L, Zhuge F,
Zheng A, Hu L, Zhao Y, Zheng L and Fu Z: Spermidine improves gut
barrier integrity and gut microbiota function in diet-induced obese
mice. Gut Microbes. 12:1–19. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiao L, Chen Y, Dou X, Song X and Xu C:
Biogenic selenium nanoparticles attenuate Aβ25-35-induced toxicity
in PC12 cells via Akt/CREB/BDNF signaling pathway. Neurotox Res.
40:1869–1881. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meng XL, Liu SY, Xue JS, Gou JM, Wang D,
Liu HS, Chen CL and Xu CB: Protective effects of liensinine,
isoliensinine, and neferine on PC12 cells injured by amyloid-β. J
Food Biochem. 46:e143032022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li LX, Liu MY, Jiang X, Xia ZH, Wang YX,
An D, Wang HG, Heng B and Liu YQ: Metformin inhibits
Aβ25-35-induced apoptotic cell death in SH-SY5Y cells.
Basic Clin Pharmacol Toxicol. 125:439–449. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Avni D, Harikumar KB, Sanyal AJ and
Spiegel S: Deletion or inhibition of SphK1 mitigates fulminant
hepatic failure by suppressing TNFα-dependent inflammation and
apoptosis. FASEB J. 35:e214152021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Etemadi N, Chopin M, Anderton H, Tanzer
MC, Rickard JA, Abeysekera W, Hall C, Spall SK, Wang B, Xiong Y, et
al: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis
and skin inflammation independently of Sphingosine kinase 1. Elife.
4:e105922015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang XX, Tan MS, Yu JT and Tan L: Matrix
metalloproteinases and their multiple roles in Alzheimer's disease.
Biomed Res Int. 2014:9086362014.PubMed/NCBI
|
|
36
|
LaFerla FM, Tinkle BT, Bieberich CJ,
Haudenschild CC and Jay G: The Alzheimer's A beta peptide induces
neurodegeneration and apoptotic cell death in transgenic mice. Nat
Genet. 9:21–30. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Viola KL and Klein WL: Amyloid β oligomers
in Alzheimer's disease pathogenesis, treatment, and diagnosis. Acta
Neuropathol. 129:183–206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Masliah E, Alford M, Adame A, Rockenstein
E, Galasko D, Salmon D, Hansen LA and Thal LJ: Abeta1-42 promotes
cholinergic sprouting in patients with AD and Lewy body variant of
AD. Neurology. 61:206–211. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kubo T, Nishimura S, Kumagae Y and Kaneko
I: In vivo conversion of racemized beta-amyloid [(D-Ser 26)A beta
1–40] to truncated and toxic fragments [(D-Ser 26)A beta 25–35/40]
and fragment presence in the brains of Alzheimer's patients. J
Neurosci Res. 70:474–483. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Frozza RL, Horn AP, Hoppe JB, Simão F,
Gerhardt D, Comiran RA and Salbego CG: A comparative study of
beta-amyloid peptides Abeta1-42 and Abeta25-35 toxicity in
organotypic hippocampal slice cultures. Neurochem Res. 34:295–303.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Varadarajan S, Kanski J, Aksenova M,
Lauderback C and Butterfield DA: Different mechanisms of oxidative
stress and neurotoxicity for Alzheimer's A beta(1–42) and A
beta(25–35). J Am Chem Soc. 123:5625–5631. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu X, Ganguly P, Jin Y, Jhatro MJ, Shea
JE, Buratto SK and Bowers MT: Tachykinin neuropeptides and amyloid
β (25–35) assembly: Friend or foe? J Am Chem Soc. 144:14614–14626.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wiatrak B, Kubis-Kubiak A, Piwowar A and
Barg E: PC12 cell line: Cell types, coating of culture vessels,
differentiation and other culture conditions. Cells. 9:9582020.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gao X, Han Z, Huang C, Lei H, Li G, Chen
L, Feng D, Zhou Z, Shi Q, Cheng L and Zhou X: An anti-inflammatory
and neuroprotective biomimetic nanoplatform for repairing spinal
cord injury. Bioact Mater. 18:569–582. 2022.PubMed/NCBI
|
|
45
|
Changhong K, Peng Y, Yuan Z and Cai J:
Ginsenoside Rb1 protected PC12 cells from
Aβ25-35-induced cytotoxicity via PPARγ activation and
cholesterol reduction. Eur J Pharmacol. 893:1738352021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Geng XD, Wang WW, Feng Z, Liu R, Cheng XL,
Shen WJ, Dong ZY, Cai GY, Chen XM, Hong Q and Wu D: Identification
of key genes and pathways in diabetic nephropathy by bioinformatics
analysis. J Diabetes Investig. 10:972–984. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gao JM, Zhang X, Shu GT, Chen NN, Zhang
JY, Xu F, Li F, Liu YG, Wei Y, He YQ, et al: Trilobatin rescues
cognitive impairment of Alzheimer's disease by targeting HMGB1
through mediating SIRT3/SOD2 signaling pathway. Acta Pharmacol Sin.
43:2482–2494. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gao J, Yao M, Zhang W, Yang B, Yuan G, Liu
JX and Zhang Y: Panax notoginseng saponins alleviates
inflammation induced by microglial activation and protects against
ischemic brain injury via inhibiting HIF-1α/PKM2/STAT3 signaling.
Biomed Pharmacother. 155:1134792022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu Y, Liu T, Ding K, Liu Z, Li Y, He T,
Zhang W, Fan Y, Ma W, Cui L and Song X: Phospholipase Cγ2 signaling
cascade contribute to the antiplatelet effect of notoginsenoside
Fc. Front Pharmacol. 9:12932018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Du Y, Fu M, Wang YT and Dong Z:
Neuroprotective effects of ginsenoside Rf on amyloid-β-induced
neurotoxicity in vitro and in vivo. J Alzheimers Dis. 64:309–322.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yan S, Li Z, Li H, Arancio O and Zhang W:
Notoginsenoside R1 increases neuronal excitability and ameliorates
synaptic and memory dysfunction following amyloid elevation. Sci
Rep. 4:63522014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ma B, Meng X, Wang J, Sun J, Ren X, Qin M,
Sun J, Sun G and Sun X: Notoginsenoside R1 attenuates
amyloid-β-induced damage in neurons by inhibiting reactive oxygen
species and modulating MAPK activation. Int Immunopharmacol.
22:151–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Fricker M, Tolkovsky AM, Borutaite V,
Coleman M and Brown GC: Neuronal cell death. Physiol Rev.
98:813–880. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yoshiyama Y, Asahina M and Hattori T:
Selective distribution of matrix metalloproteinase-3 (MMP-3) in
Alzheimer's disease brain. Acta Neuropathol. 99:91–95. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Backstrom JR, Lim GP, Cullen MJ and Tökés
ZA: Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of
the human hippocampus and is capable of degrading the amyloid-beta
peptide (1–40). J Neurosci. 16:7910–7919. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ito S, Kimura K, Haneda M, Ishida Y,
Sawada M and Isobe KI: Induction of matrix metalloproteinases
(MMP3, MMP12 and MMP13) expression in the microglia by amyloid-beta
stimulation via the PI3K/Akt pathway. Exp Gerontol. 42:532–537.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lorenzl S, Buerger K, Hampel H and Beal
MF: Profiles of matrix metalloproteinases and their inhibitors in
plasma of patients with dementia. Int Psychogeriatr. 20:67–76.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Nübling G, Levin J, Bader B, Israel L,
Bötzel K, Lorenzl S and Giese A: Limited cleavage of tau with
matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau
oligomer formation. Exp Neurol. 237:470–476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Poti F, Ceglarek U, Burkhardt R, Simoni M
and Nofer JR: SKI–II-a sphingosine kinase 1 inhibitor-exacerbates
atherosclerosis in low-density lipoprotein receptor-deficient
(LDL-R-/-) mice on high cholesterol diet. Atherosclerosis.
240:212–215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lee JY, Han SH, Park MH, Baek B, Song IS,
Choi MK, Takuwa Y, Ryu H, Kim SH, He X, et al: Neuronal SphK1
acetylates COX2 and contributes to pathogenesis in a model of
Alzheimer's disease. Nat Commun. 9:14792018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Uddin MS and Lim LW: Glial cells in
Alzheimer's disease: From neuropathological changes to therapeutic
implications. Ageing Res Rev. 78:1016222022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cherifi C, Latourte A, Vettorazzi S,
Tuckermann J, Provot S, Ea HK, Ledoux A, Casas J, Cuvillier O,
Richette P, et al: Inhibition of sphingosine 1-phosphate protects
mice against chondrocyte catabolism and osteoarthritis.
Osteoarthritis Cartilage. 29:1335–1345. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lai WQ, Irwan AW, Goh HH, Howe HS, Yu DT,
Valle-Oñate R, McInnes IB, Melendez AJ and Leung BP:
Anti-inflammatory effects of sphingosine kinase modulation in
inflammatory arthritis. J Immunol. 181:8010–8017. 2008. View Article : Google Scholar : PubMed/NCBI
|
